Skip to main content
Erschienen in: BMC Urology 1/2023

Open Access 01.12.2023 | Research

Efficacy of emergency extracorporeal shock wave lithotripsy in the treatment of ureteral stones: a meta-analysis

verfasst von: Cheng-Xia Peng, Yi-Kai Lou, Li Xu, Guang-Hao Wu, Xie-Lai Zhou, Kang-Er Wang, Chun-Hua Ye

Erschienen in: BMC Urology | Ausgabe 1/2023

Abstract

Objective

To compare the clinical efficiency and safety of emergency extracorporeal shock wave lithotripsy (eESWL) and delayed extracorporeal shock wave lithotripsy (dESWL) in the treatment of ureteral stones.

Methods

Cochrane Library, PubMed, Google Scholar, and Web of Science were searched from January 1, 1992 to September 30, 2022, and all comparative studies involving eESWL and dESWL for ureteral calculi were included. Statistical analysis was performed using Review Manager 5.3 software. Funnel plot was used to evaluated publication bias.

Results

A total of 9 articles involving 976 patients diagnosed with ureteral stones were included. The results showed that the stone-free rate (SFR) after four weeks was significantly higher in the eESWL group than in the dESWL group [relative risk (RR) = 1.22, 95% confidence interval (CI): 1.13–1.32, P < 0.01]. In subgroup analysis of different stone locations, proximal ureteral calculi [RR = 1.25, 95% CI: 1.14–1.38, P < 0.01] and mid-to-distal ureteral calculi [RR = 1.18, 95% CI: 1.03–1.34, P < 0.05] all showed a higher SFR in the eESWL group. eESWL significantly shortened the stone-free time(SFT) [mean difference (MD) = -5.75, 95% CI: -9.33 to -2.17, P < 0.01]. In addition, eESWL significantly reduced auxiliary procedures [RR = 0.53, 95% CI: 0.40–0.70, P < 0.01]. No significant difference in complications was found between the two groups [RR = 0.90, 95% CI: 0.69–1.16, P > 0.05].

Conclusion

eESWL can significantly improve SFR, shorten SFT, and reduce auxiliary procedures.
Hinweise

Supplementary Information

The online version contains supplementary material available at https://​doi.​org/​10.​1186/​s12894-023-01226-5.

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Background

Renal colic (RC) caused by ureteral calculi is one of the most common emergencies encountered by urologists in clinical practice. Conservative treatment, extracorporeal shock wave lithotripsy (ESWL), ureteroscopic lithotripsy (URS), and laparoscopic or open surgery are the common methods for the treatment of ureteral calculi to relieve RC [1]. Usually, whether a ureteral stone can be spontaneously expelled depends on the size and shape of the stone, as well as its location in the ureter [2]. For stones > 6 mm in diameter, the chances of spontaneous expulsion are significantly reduced [1]. Conservative treatment is usually accompanied by recurrent RC, repeated emergency department visits, and loss of work ability, and long-term conservative treatment may be associated with complications such as infection, ureteral stricture, and renal function impairment [2].
Since its advent in the 1980s, ESWL has long been considered the first-choice treatment for upper urinary tract stones due to its simplicity, non-invasiveness, fewer complications, and low cost [3]. It is recommended by the European Association of Urology (EAU) guidelines for the management of urinary stones, which state that the three-month stone-free rate (SFR) is 82% for the proximal ureter, 3% for the middle ureter, and 74% for the distal ureter for ureteral calculi smaller than 2 cm [4, 5].
However, for patients with acute RC, conservative therapy such as spasmolysis and pain relief is performed first, while lithotripsy, whether ESWL or URS is often delayed. Delayed lithotripsy is often associated with recurrent RC, possible urinary tract infections, and azotaemia [6]. For patients with these conditions, treatment should focus on relieving pain and removing stones as soon as possible, while reducing complications. Kravchick and colleagues [7] conducted a randomized controlled trial (RCT) to investigate the efficacy of emergency extracorporeal shock wave lithotripsy (eESWL) in ureteral stones and concluded that ESWL within 48–72 h after RC relieves obstruction and pain more quickly, which is a safe and effective treatment. Tombal et al. [8] found that ESWL within 6 h was associated with faster stone clearance and shorter hospital stays. Choi et al. [9] showed that compared to delayed extracorporeal shock wave lithotripsy (dESWL), patients receiving eESWL experienced a significantly higher rate of treatment success, quicker stone expulsion, and fewer ESWL sessions. A growing number of studies have confirmed that eESWL is efficacious and safe for treating ureteral stones; therefore, the present study sought to evaluate the role of eESWL in ureteral stone expulsion through a comprehensive meta-analysis.

Methods

Search strategy and study selection

This meta-analysis was conducted according to Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines [10]. Relevant studies were searched on PubMed, Web of Science, Cochrane Library, and Google Scholar from January 1, 1992 to September 30, 2022, without language restriction. Search terms included: “emergency”, “urgency”, “extracorporeal shockwave lithotripsy”, “ureteral stones”, “ureteral calculi”, “ureteral urolithiasis”, and “ureteric stones”. Our study protocol was registered on PROSPERO (No. CRD42023407392).
The inclusion criteria were as follows. (1) Comparative study of eESWL and dESWL in the treatment of ureteral calculi. (2) Stone characteristics: unilateral, single ureteral calculi, stone diameter < 2 cm. (3) Intervention measures: the experimental group was eESWL (ESWL within 48–72 h of RC attack) and the control group was dESWL (ESWL after 48–72 h of RC attack). (4) Outcome measures: at least one of the SFR of the proximal ureteral calculi, SFR of the mid-to-distal ureteral calculi, overall SFR, stone-free time (SFT), complications, and auxiliary procedures. Exclusion criteria were: (1) case reports, reviews, editorial comments, and conference abstracts; (2) duplicate publications; (3) data not available or extractable.

Data extraction and quality assessment

Two researchers independently performed the literature search and assessed the eligibility of studies based on the inclusion and exclusion criteria by reading the titles and abstracts. Any discrepancies were resolved through a consensus discussion with a third researcher. The following information was extracted: (1) general data, including the first author, publication time, country, and type of literature; (2) patient characteristics, including the number of experimental group and control group, intervention measures, stone size, stone location; (3) outcome measures: SFR, SFT(day), the incidence of complications, and auxiliary procedures. We performed subgroup analysis according to the location of calculi, including proximal ureteral calculi group and mid-to-distal ureteral calculi group. The Newcastle-Ottawa Scale (NOS) was used to evaluate the quality of non-randomised studies. NOS scores were assessed on a 9-point scale. A score of 0–3, 4–6, and 7–9 represents a low, moderate, and high quality, respectively. The Cochrane Collaboration tool was used to evaluate the risk bias of RCTs as follows: low, unclear, and high risk of bias.

Statistical analysis

Review Manager 5.3 software was used for statistical analysis (Cochrane Collaboration, Oxford, United Kingdom). Relative risk (RR) was used as the effective index for dichotomous variables, whereas mean difference (MD) was used for continuous variables. The results were expressed as a 95% confidence interval (CI). The statistical significance level was set at P < 0.05. χ2 and I2 were used to test the heterogeneity among the results of each study. A random-effects model was adopted for pooled analysis when statistical heterogeneity was found (I2 ≥ 50%, P ≤ 0.1), while a fixed-effects model was adopted when no significant heterogeneity was detected (I2 < 50% and P > 0.1). The ultimate results are presented in forest plots. And publication bias was evaluated through funnel plot. .

Results

Search results and study characteristics

A total of 9 articles were retrieved, including 5 RCTs and 4 retrospective studies. The flow diagram of the literature screening process is shown in Fig. 1. The quality evaluation of the studies are shown in Table 1. All studies were of high quality. A total of 976 patients were included in the study, of whom 488 patients underwent ESWL within 48–72 h of the onset of RC as an intervention. The remaining 488 patients underwent ESWL after 48–72 h, and the mean follow-up time for all patients was 4 weeks. A summary of the included studies is shown in Table 2.
Table 1
Newcastle-Ottawa Scale and Cochrane Collaboration tool for quality evaluation of the studies
  
Selection
Comparability
Outcome
 
Study
Design
Representativeness
of exposed cohort
Selective of
nonexposed Cohort
Ascertainment
of exposure
Outcome not
present at start
 
Assessment
of outcome
Adequate
follow-up length
Adequacy
of follow-up
Total
Choi 2012
R
*
*
*
*
*
*
*
 
7
Cornelius 2020
R
*
*
*
*
**
*
*
*
9
Joshi 1999
R
*
*
*
*
*
*
*
*
8
Seitz 2005
R
*
*
*
*
*
 
*
*
7
  
Random sequence generation
Allocation concealment
Blinding of participant and personnel
Blinding of outcome assessment
Incomplete outcome data
Selective reporting
Other bias
  
Bucci 2018
RCT
Low
Unclear
Low
Low
Low
Low
Unclear
  
Kravchick 2005
RCT
Low
Unclear
Unclear
Unclear
Low
Low
Low
  
Kumar 2010
RCT
Low
Unclear
Low
Low
Low
Low
Low
  
Tombal 2005
RCT
Unclear
Unclear
Unclear
Low
Low
Low
Low
  
Uguz 2012
RCT
Low
Low
Low
Low
Low
Low
Unclear
  
* signifies score, RCT: Randomised controlled trial, R: Retrospectively study
Table 2
Characteristics of studies
Study
Country
Design
Therapy in the experimental group
Therapy in the control group
Sample size:
experiment/control
Stone size:
experiment/control, mm
Location of stone
       
Proximal
ureter
Mid-to-distal
ureter
Bucci 2018 [11]
Italy
RCT
ESWL within 12 h
dESWL
36/34
9.03/10.68
25
45
Choi
2012 [9]
Korea
R
ESWL within 48 h
dESWL
153/126
7.6 ± 2.5/8.3 ± 3.1
183
96
Cornelius 2020 [12]
Italy
R
ESWL within 48 h
dESWL
52/52
7.1 ± 1.9/7.2 ± 1.9
80
24
Joshi 1999 [13]
UK
R
ESWL within 48 h
dESWL
16/40
8.2/9.3
37
19
Kravchick 2005 [7]
Israel
RCT
ESWL within 48 to 72 h
dESWL
25/28
7.4 ± 2.4/6.9 ± 2.4
53
NA
Kumar 2010 [14]
India
RCT
ESWL within 48 h
dESWL
80/80
7.3 ± 1.5/7.5 ± 1.7
160
NA
Seitz 2005 [15]
Austria
R
ESWL within 48 h
dESWL
44/47
8.0 ± 2.4/8.1 ± 2.1
91
NA
Tombal 2005 [8]
Belgium
RCT
ESWL within 6 h
dESWL
50/50
6.38/4.8
46
54
Uguz 2012 [16]
Turkey
RCT
ESWL within 24 h
dESWL
32/31
8.1 ± 3.2/8.8 ± 2.9
41
22
RCT: Randomised controlled trial, R: Retrospectively study, NA: not available, ESWL: emergency extracorporeal shock wave lithotripsy, dESWL: delayed extracorporeal shock wave lithotripsy

Stone-free rate

The overall SFR was reported in all included studies, and eESWL increased the SFR compared with the control group [RR = 1.22, 95% CI: 1.13–1.32, I2 = 0%, P < 0.01] (Fig. 2). The SFR for proximal ureteral calculi was reported in eight of the articles, and the results showed that eESWL significantly improved SFR [RR = 1.25, 95% CI: 1.14–1.38, I2 = 35%, P < 0.01] (Fig. 3). Five studies reported SFRs for the mid-to-distal ureteral calculi, and the results also showed a higher SFR with eESWL [RR = 1.18, 95% CI: 1.03–1.34, I2 = 0%, P < 0.05] (Fig. 4).

Stone-free time

Stone free time was reported in three articles, and the results showed that the time required for stone expulsion was significantly shorter in eESWL group than in dESWL group [MD = -5.75, 95% CI (-9.33, -2.17), I2 = 39%, P < 0.01] (Fig. 5).

Auxiliary procedure

Residual stones ≤ 4 mm in diameter are called insignificant residual stones, and additional ureteroscopic lithotripsy is performed as an auxiliary procedure to expel the stones if the diameter of residual stones after surgery is > 4 mm. Eight studies reported stone removal by the auxiliary procedure. The results showed that the rate of auxiliary procedure required by eESWL was significantly lower than that required by dESWL [RR = 0.53, 95% CI: 0.40–0.70, I2 = 44%, P < 0.01] (Fig. 6).

Complications

Postoperative complications after ESWL include recurrence of RC, fever, steinstrasse formation, azotaemia, and perirenal hematoma. The complication rate was reported in five articles, and the results showed that eESWL had a lower complication rate than dESWL [RR = 0.90, 95% CI: 0.69–1.16, I2 = 0%, P > 0.05] (Fig. 7), but no statistically significant was detected between the two methods.

Publication bias

No significant asymmetry was observed in funnel plots, which indicated no publication bias (Fig. 8).

Discussion

The rationale for performing eESWL is mainly based on the finding that ureteral mucosal oedema starts after 24–48 h of stone obstruction, and progresses over time [17]. Therefore, ureteral mucosal oedema is closely related to the development of stone obstruction. A previous study demonstrated morphologic changes of the mucosa in the stone bed after 48 h, such as a marked increase in hyperplasia and mitotic activity in histologic examinations [18]. This gradual increase in ureteral mucosal oedema prevents luminal distension and the formation of fluid interfaces, impeding adequate delivery of shock wave energy, which decreases fragmentation and expulsion of stones [19]. Furthermore, Cummins et al. [20] showed that the duration after symptom onset was the most important predictor of ureteral stone removal. Therefore, the rationale for applying eESWL to treat RC caused by ureteral calculi is to achieve maximal SFR before the development or progression of peripheral mucosal oedema.
Herein, we conducted a systematic review and meta-analysis on the efficacy of eESWL and dESWL in the treatment of ureteral stones based on nine comparative clinical studies with 4 weeks of follow-up. This study compared the short-term follow-up results of patients who underwent eESWL and dESWL, which showed no significant difference in the incidence of complications. However, the eESWL group had higher SFR, fewer SFT, and reduced auxiliary procedures.
SFR after lithotripsy is an important reference for surgical results. Our study showed that eESWL significantly increased the SFR (P < 0.01, Fig. 2). Both proximal and mid-to-distal ureteral calculi showed a higher SFR (P < 0.05, Figs. 3 and 4). Tombal et al. [8] showed that eESWL was an efficient treatment for stones, with significantly higher stone clearance in patients with proximal calculi than in those with distal calculi, improving the success rate by more than 35%. Choi et al. [9] showed that eESWL is a reliable and efficient way to manage urinary stones, particularly proximal ureteral stones. Arrabal-Martin et al. [21] showed that the success of ESWL was comparable to ureteroscopy in proximal calculi. The reason may be that distal ureteral calculi are greatly affected by the bowel and pelvis, which can disturb the localisation of the target stone and transmission of shock waves to the target stone [22].
SFT after lithotripsy can also be used as a reference for surgical outcomes. Our study showed that eESWL significantly shortened the time required for stone expulsion (P < 0.01, Fig. 5). ESWL does not immediately achieve a stone-free status and may take some time to eliminate fragmented ureteral stones depending on various factors, such as the size and location of the stone, degree of stone impaction, and degree of ureteral mucosal oedema [23]. eESWL is performed to maximise stone clearance when ureteral mucosal oedema reaches the apex. Seitz et al. [15] showed that eESWL required significantly fewer shock sessions than dESWL.
Meanwhile, the current study showed that the need for auxiliary procedures after eESWL was much lower than after dESWL (P < 0.01, Fig. 6). This can be explained by the above pathophysiological principles that oedema and hyperplasia of the ureteral mucosa due to stone obstruction limit the luminal distension and formation of fluid interfaces [19]. This not only reduces the fragmentation rate after ESWL but also compromises stone clearance, simultaneously increasing the sessions of ESWL and the need for ureteroscopic lithotripsy.
Our study found no statistically significant difference in complications between the eESWL and dESWL groups. Generally, complications after ESWL are short-term and mild, the most common of which are RC, haematuria, urinary tract infection, and perirenal hematoma [24]. Kumar et al. [14] showed a slightly higher incidence of haematuria in the dESWL group compared with the eESWL group (41.3 vs. 38.8%, P < 0.05) and a higher rate of steinstrasse formation (12.5 vs. 6.25%, P < 0.05). Bucci et al. [11] reported a case of acute pyelonephritis due to postoperative steinstrasse in the dESWL group who underwent emergent double-J tube placement and intravenous antibiotics. Blackwell et al. [25] conducted a study that included 10,301 patients hospitalised for acute ureteral obstruction and found that early intervention reduced mortality by 0.16% compared with delayed intervention; they concluded that early intervention reduced patient mortality in some way.
This study has some limitations. First, not all of the included articles were RCTs, which reduced the quality of the included articles. Second, factors affecting lithotripsy, such as stone composition and distance from stone to skin, were not performed in the subgroup analysis, which may lead to biased results. Third, some studies used kidney-ureter-bladder X-ray rather than computed tomography to assess residual stones, and different authors had different definitions of stone-free status, which may also lead to biased results. Finally, the follow-up time was too short.

Conclusion

In summary, eESWL is a safe and effective treatment for ureteral calculi, which can significantly improve the SFR, shorten the SFT, and reduce auxiliary procedures.

Acknowledgements

Not applicable.

Declarations

Not applicable.
Not applicable.

Competing interests

The authors declare that they have no competing interests.
Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://​creativecommons.​org/​licenses/​by/​4.​0/​. The Creative Commons Public Domain Dedication waiver (http://​creativecommons.​org/​publicdomain/​zero/​1.​0/​) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Literatur
1.
2.
3.
Zurück zum Zitat Talso M, Tefik T, Mantica G, Rodriguez SM, Kartalas GI, Somani BK, et al. Extracorporeal shockwave lithotripsy: current knowledge and future perspectives. Minerva Urol Nefrol. 2019;71:365–72.CrossRefPubMed Talso M, Tefik T, Mantica G, Rodriguez SM, Kartalas GI, Somani BK, et al. Extracorporeal shockwave lithotripsy: current knowledge and future perspectives. Minerva Urol Nefrol. 2019;71:365–72.CrossRefPubMed
4.
Zurück zum Zitat Türk C, Petřík A, Sarica K, Seitz C, Skolarikos A, Straub M, et al. EAU Guidelines on Interventional Treatment for Urolithiasis. Eur Urol. 2016;69:475–82.CrossRefPubMed Türk C, Petřík A, Sarica K, Seitz C, Skolarikos A, Straub M, et al. EAU Guidelines on Interventional Treatment for Urolithiasis. Eur Urol. 2016;69:475–82.CrossRefPubMed
5.
Zurück zum Zitat Chen X, Chen J, Zhou X, Long Q, He H, Li X. Is there a place for extracorporeal shockwave lithotripsy (ESWL) in the endoscopic era? Urolithiasis. 2022;50:369–74.CrossRefPubMed Chen X, Chen J, Zhou X, Long Q, He H, Li X. Is there a place for extracorporeal shockwave lithotripsy (ESWL) in the endoscopic era? Urolithiasis. 2022;50:369–74.CrossRefPubMed
6.
Zurück zum Zitat Ogreden E, Demirelli E, Aksu M, Tok DS, Oğuz U. Early ureteroscopic lithotripsy in acute renal colic caused by ureteral calculi. Int Urol Nephrol. 2020;52:15–9.CrossRefPubMed Ogreden E, Demirelli E, Aksu M, Tok DS, Oğuz U. Early ureteroscopic lithotripsy in acute renal colic caused by ureteral calculi. Int Urol Nephrol. 2020;52:15–9.CrossRefPubMed
7.
Zurück zum Zitat Kravchick S, Bunkin I, Stepnov E, Peled R, Agulansky L, Cytron S. Emergency extracorporeal shockwave lithotripsy for acute renal colic caused by upper urinary-tract stones. J Endourol. 2005;19:1–4.CrossRefPubMed Kravchick S, Bunkin I, Stepnov E, Peled R, Agulansky L, Cytron S. Emergency extracorporeal shockwave lithotripsy for acute renal colic caused by upper urinary-tract stones. J Endourol. 2005;19:1–4.CrossRefPubMed
8.
Zurück zum Zitat Tombal B, Mawlawi H, Feyaerts A, Wese FX, Opsomer R, Van Cangh PJ. Prospective randomized evaluation of emergency extracorporeal shock wave lithotripsy (ESWL) on the short-time outcome of symptomatic ureteral stones. Eur Urol. 2005;47:855–9.CrossRefPubMed Tombal B, Mawlawi H, Feyaerts A, Wese FX, Opsomer R, Van Cangh PJ. Prospective randomized evaluation of emergency extracorporeal shock wave lithotripsy (ESWL) on the short-time outcome of symptomatic ureteral stones. Eur Urol. 2005;47:855–9.CrossRefPubMed
9.
Zurück zum Zitat Choi HJ, Jung JH, Bae J, Cho MC, Lee HW, Lee KS. Usefulness of early extracorporeal shock wave lithotripsy in colic patients with ureteral stones. Korean J Urol. 2012;53:853–9.CrossRefPubMedPubMedCentral Choi HJ, Jung JH, Bae J, Cho MC, Lee HW, Lee KS. Usefulness of early extracorporeal shock wave lithotripsy in colic patients with ureteral stones. Korean J Urol. 2012;53:853–9.CrossRefPubMedPubMedCentral
10.
Zurück zum Zitat Moher D, Liberati A, Tetzlaff J, Altman DG. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med. 2009;6:e1000097.CrossRefPubMedPubMedCentral Moher D, Liberati A, Tetzlaff J, Altman DG. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med. 2009;6:e1000097.CrossRefPubMedPubMedCentral
11.
Zurück zum Zitat Bucci S, Umari P, Rizzo M, Pavan N, Liguori G, Barbone F, et al. Emergency extracorporeal shockwave lithotripsy as opposed to delayed shockwave lithotripsy for the treatment of acute renal colic due to obstructive ureteral stone: a prospective randomized trial. Minerva Urol Nefrol. 2018;70:526–33.CrossRefPubMed Bucci S, Umari P, Rizzo M, Pavan N, Liguori G, Barbone F, et al. Emergency extracorporeal shockwave lithotripsy as opposed to delayed shockwave lithotripsy for the treatment of acute renal colic due to obstructive ureteral stone: a prospective randomized trial. Minerva Urol Nefrol. 2018;70:526–33.CrossRefPubMed
12.
Zurück zum Zitat Cornelius J, Zumbühl D, Afferi L, Mordasini L, Di Bona C, Zamboni S, et al. Immediate Shockwave lithotripsy vs delayed shockwave lithotripsy after urgent ureteral stenting in patients with Ureteral or Pyeloureteral Urolithiasis: a matched-pair analysis. J Endourol. 2021;35:721–7.CrossRefPubMed Cornelius J, Zumbühl D, Afferi L, Mordasini L, Di Bona C, Zamboni S, et al. Immediate Shockwave lithotripsy vs delayed shockwave lithotripsy after urgent ureteral stenting in patients with Ureteral or Pyeloureteral Urolithiasis: a matched-pair analysis. J Endourol. 2021;35:721–7.CrossRefPubMed
13.
Zurück zum Zitat Joshi HB, Obadeyi OO, Rao PN. A comparative analysis of nephrostomy, JJ stent and urgent in situ extracorporeal shock wave lithotripsy for obstructing ureteric stones. BJU Int. 1999;84:264–9.CrossRefPubMed Joshi HB, Obadeyi OO, Rao PN. A comparative analysis of nephrostomy, JJ stent and urgent in situ extracorporeal shock wave lithotripsy for obstructing ureteric stones. BJU Int. 1999;84:264–9.CrossRefPubMed
14.
Zurück zum Zitat Kumar A, Mohanty NK, Jain M, Prakash S, Arora RP. A prospective randomized comparison between early (< 48 hours of onset of colicky pain) versus delayed shockwave lithotripsy for symptomatic upper ureteral calculi: a single center experience. J Endourol. 2010;24:2059–66.CrossRefPubMed Kumar A, Mohanty NK, Jain M, Prakash S, Arora RP. A prospective randomized comparison between early (< 48 hours of onset of colicky pain) versus delayed shockwave lithotripsy for symptomatic upper ureteral calculi: a single center experience. J Endourol. 2010;24:2059–66.CrossRefPubMed
15.
Zurück zum Zitat Seitz C, Fajković H, Remzi M, Waldert M, Ozsoy M, Kramer G et al. Rapid extracorporeal shock wave lithotripsy treatment after a first colic episode correlates with accelerated ureteral stone clearance.Eur Urol. 2006;49:1099 – 105; discussion 1105-6. Seitz C, Fajković H, Remzi M, Waldert M, Ozsoy M, Kramer G et al. Rapid extracorporeal shock wave lithotripsy treatment after a first colic episode correlates with accelerated ureteral stone clearance.Eur Urol. 2006;49:1099 – 105; discussion 1105-6.
16.
Zurück zum Zitat Uguz S, Senkul T, Soydan H, Ates F, Akyol I, Malkoc E, et al. Immediate or delayed SWL in ureteric stones: a prospective and randomized study. Urol Res. 2012;40:739–44.CrossRefPubMed Uguz S, Senkul T, Soydan H, Ates F, Akyol I, Malkoc E, et al. Immediate or delayed SWL in ureteric stones: a prospective and randomized study. Urol Res. 2012;40:739–44.CrossRefPubMed
17.
Zurück zum Zitat Panah A, Patel S, Bourdoumis A, Kachrilas S, Buchholz N, Masood J. Factors predicting success of emergency extracorporeal shockwave lithotripsy (eESWL) in ureteric calculi–a single centre experience from the United Kingdom (UK). Urolithiasis. 2013;41:437–41.CrossRefPubMed Panah A, Patel S, Bourdoumis A, Kachrilas S, Buchholz N, Masood J. Factors predicting success of emergency extracorporeal shockwave lithotripsy (eESWL) in ureteric calculi–a single centre experience from the United Kingdom (UK). Urolithiasis. 2013;41:437–41.CrossRefPubMed
18.
Zurück zum Zitat Wagenius M, Oddason K, Utter M, Popiolek M, Forsvall A, Lundström KJ, et al. Factors influencing stone-free rate of extracorporeal shock Wave lithotripsy (ESWL); a cohort study. Scand J Urol. 2022;56:237–43.CrossRefPubMed Wagenius M, Oddason K, Utter M, Popiolek M, Forsvall A, Lundström KJ, et al. Factors influencing stone-free rate of extracorporeal shock Wave lithotripsy (ESWL); a cohort study. Scand J Urol. 2022;56:237–43.CrossRefPubMed
19.
Zurück zum Zitat Al-Zubi M, Al SA, Elayan BM, Al-Issawi SZ, Bani-Hani M, Alsharei A, et al. The effect of stone and patient characteristics in predicting extra-corporal shock wave lithotripsy success rate: a cross sectional study. Ann Med Surg (Lond). 2021;70:102829.CrossRefPubMed Al-Zubi M, Al SA, Elayan BM, Al-Issawi SZ, Bani-Hani M, Alsharei A, et al. The effect of stone and patient characteristics in predicting extra-corporal shock wave lithotripsy success rate: a cross sectional study. Ann Med Surg (Lond). 2021;70:102829.CrossRefPubMed
20.
Zurück zum Zitat Cummings JM, Boullier JA, Izenberg SD, Kitchens DM, Kothandapani RV. Prediction of spontaneous ureteral calculous passage by an artificial neural network. J Urol. 2000;164:326–8.CrossRefPubMed Cummings JM, Boullier JA, Izenberg SD, Kitchens DM, Kothandapani RV. Prediction of spontaneous ureteral calculous passage by an artificial neural network. J Urol. 2000;164:326–8.CrossRefPubMed
21.
Zurück zum Zitat Arrabal-Martín M, Pareja-Vilches M, Gutiérrez-Tejero F, Miján-Ortiz JL, Palao-Yago F, Zuluaga-Gómez A. Therapeutic options in lithiasis of the lumbar ureter. Eur Urol. 2003;43:556–63.CrossRefPubMed Arrabal-Martín M, Pareja-Vilches M, Gutiérrez-Tejero F, Miján-Ortiz JL, Palao-Yago F, Zuluaga-Gómez A. Therapeutic options in lithiasis of the lumbar ureter. Eur Urol. 2003;43:556–63.CrossRefPubMed
22.
Zurück zum Zitat Kroczak T, Scotland KB, Chew B, Pace KT. Shockwave lithotripsy: techniques for improving outcomes. World J Urol. 2017;35:1341–6.CrossRefPubMed Kroczak T, Scotland KB, Chew B, Pace KT. Shockwave lithotripsy: techniques for improving outcomes. World J Urol. 2017;35:1341–6.CrossRefPubMed
23.
Zurück zum Zitat Lawler AC, Ghiraldi EM, Tong C, Friedlander JI. Extracorporeal shock Wave Therapy: current perspectives and future directions. Curr Urol Rep. 2017;18:25.CrossRefPubMed Lawler AC, Ghiraldi EM, Tong C, Friedlander JI. Extracorporeal shock Wave Therapy: current perspectives and future directions. Curr Urol Rep. 2017;18:25.CrossRefPubMed
24.
Zurück zum Zitat Wagenius M, Jakobsson J, Stranne J, Linder A. Complications in extracorporeal shockwave lithotripsy: a cohort study. Scand J Urol. 2017;51:407–13.CrossRefPubMed Wagenius M, Jakobsson J, Stranne J, Linder A. Complications in extracorporeal shockwave lithotripsy: a cohort study. Scand J Urol. 2017;51:407–13.CrossRefPubMed
25.
Zurück zum Zitat Blackwell RH, Barton GJ, Kothari AN, Zapf MA, Flanigan RC, Kuo PC, et al. Early intervention during Acute Stone admissions: revealing “The Weekend Effect” in Urological Practice. J Urol. 2016;196:124–30.CrossRefPubMedPubMedCentral Blackwell RH, Barton GJ, Kothari AN, Zapf MA, Flanigan RC, Kuo PC, et al. Early intervention during Acute Stone admissions: revealing “The Weekend Effect” in Urological Practice. J Urol. 2016;196:124–30.CrossRefPubMedPubMedCentral
Metadaten
Titel
Efficacy of emergency extracorporeal shock wave lithotripsy in the treatment of ureteral stones: a meta-analysis
verfasst von
Cheng-Xia Peng
Yi-Kai Lou
Li Xu
Guang-Hao Wu
Xie-Lai Zhou
Kang-Er Wang
Chun-Hua Ye
Publikationsdatum
01.12.2023
Verlag
BioMed Central
Erschienen in
BMC Urology / Ausgabe 1/2023
Elektronische ISSN: 1471-2490
DOI
https://doi.org/10.1186/s12894-023-01226-5

Weitere Artikel der Ausgabe 1/2023

BMC Urology 1/2023 Zur Ausgabe

Alphablocker schützt vor Miktionsproblemen nach der Biopsie

16.05.2024 alpha-1-Rezeptorantagonisten Nachrichten

Nach einer Prostatabiopsie treten häufig Probleme beim Wasserlassen auf. Ob sich das durch den periinterventionellen Einsatz von Alphablockern verhindern lässt, haben australische Mediziner im Zuge einer Metaanalyse untersucht.

Neue S3-Leitlinie zur unkomplizierten Zystitis: Auf Antibiotika verzichten?

15.05.2024 Harnwegsinfektionen Nachrichten

Welche Antibiotika darf man bei unkomplizierter Zystitis verwenden und wovon sollte man die Finger lassen? Welche pflanzlichen Präparate können helfen? Was taugt der zugelassene Impfstoff? Antworten vom Koordinator der frisch überarbeiteten S3-Leitlinie, Prof. Florian Wagenlehner.

Viel pflanzliche Nahrung, seltener Prostata-Ca.-Progression

12.05.2024 Prostatakarzinom Nachrichten

Ein hoher Anteil pflanzlicher Nahrung trägt möglicherweise dazu bei, das Progressionsrisiko von Männern mit Prostatakarzinomen zu senken. In einer US-Studie war das Risiko bei ausgeprägter pflanzlicher Ernährung in etwa halbiert.

Darf man die Behandlung eines Neonazis ablehnen?

08.05.2024 Gesellschaft Nachrichten

In einer Leseranfrage in der Zeitschrift Journal of the American Academy of Dermatology möchte ein anonymer Dermatologe bzw. eine anonyme Dermatologin wissen, ob er oder sie einen Patienten behandeln muss, der eine rassistische Tätowierung trägt.

Update Urologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.